Hair disorders in cancer survivors

Azael Freites-Martinez, Jerry Shapiro, Corina van den Hurk, Shari Goldfarb, Joaquin J. Jimenez, Anthony M. Rossi, Ralf Paus, Mario E. Lacouture

Research output: Contribution to journalReview article

4 Citations (Scopus)

Abstract

With increasing survival rates across all cancers, survivors represent a growing population that is frequently affected by persistent or permanent hair growth disorders as a result of systemic therapies, radiotherapy, surgical procedures, and therapeutic transplants. These hair disorders include persistent chemotherapy-induced alopecia, persistent radiotherapy-induced alopecia, endocrine therapy–induced alopecia and hirsutism, postsurgery alopecia and localized hypertrichosis, and persistent stem cell transplantation and targeted therapy-induced alopecia. The information contained in this continuing medical education series should facilitate a better understanding on hair disorders in cancer survivors so that adequate support and therapies may be provided.

Original languageEnglish (US)
Pages (from-to)1199-1213
Number of pages15
JournalJournal of the American Academy of Dermatology
Volume80
Issue number5
DOIs
StatePublished - May 1 2019

Fingerprint

Alopecia
Neoplasms
Radiotherapy
Hypertrichosis
Growth Disorders
Hirsutism
Continuing Medical Education
Stem Cell Transplantation
Therapeutics
Transplants
Drug Therapy
Population

Keywords

  • alopecia
  • cancer survivors
  • cancer therapy
  • endocrine therapy
  • hirsutism
  • hypertrichosis
  • persistent alopecia
  • persistent chemotherapy-induced alopecia
  • persistent radiotherapy-induced alopecia
  • quality of life
  • therapeutic transplants

ASJC Scopus subject areas

  • Dermatology

Cite this

Freites-Martinez, A., Shapiro, J., van den Hurk, C., Goldfarb, S., Jimenez, J. J., Rossi, A. M., ... Lacouture, M. E. (2019). Hair disorders in cancer survivors. Journal of the American Academy of Dermatology, 80(5), 1199-1213. https://doi.org/10.1016/j.jaad.2018.03.056

Hair disorders in cancer survivors. / Freites-Martinez, Azael; Shapiro, Jerry; van den Hurk, Corina; Goldfarb, Shari; Jimenez, Joaquin J.; Rossi, Anthony M.; Paus, Ralf; Lacouture, Mario E.

In: Journal of the American Academy of Dermatology, Vol. 80, No. 5, 01.05.2019, p. 1199-1213.

Research output: Contribution to journalReview article

Freites-Martinez, A, Shapiro, J, van den Hurk, C, Goldfarb, S, Jimenez, JJ, Rossi, AM, Paus, R & Lacouture, ME 2019, 'Hair disorders in cancer survivors', Journal of the American Academy of Dermatology, vol. 80, no. 5, pp. 1199-1213. https://doi.org/10.1016/j.jaad.2018.03.056
Freites-Martinez A, Shapiro J, van den Hurk C, Goldfarb S, Jimenez JJ, Rossi AM et al. Hair disorders in cancer survivors. Journal of the American Academy of Dermatology. 2019 May 1;80(5):1199-1213. https://doi.org/10.1016/j.jaad.2018.03.056
Freites-Martinez, Azael ; Shapiro, Jerry ; van den Hurk, Corina ; Goldfarb, Shari ; Jimenez, Joaquin J. ; Rossi, Anthony M. ; Paus, Ralf ; Lacouture, Mario E. / Hair disorders in cancer survivors. In: Journal of the American Academy of Dermatology. 2019 ; Vol. 80, No. 5. pp. 1199-1213.
@article{f25f0c5f5d4b464989be9a82fe4dbd5a,
title = "Hair disorders in cancer survivors",
abstract = "With increasing survival rates across all cancers, survivors represent a growing population that is frequently affected by persistent or permanent hair growth disorders as a result of systemic therapies, radiotherapy, surgical procedures, and therapeutic transplants. These hair disorders include persistent chemotherapy-induced alopecia, persistent radiotherapy-induced alopecia, endocrine therapy–induced alopecia and hirsutism, postsurgery alopecia and localized hypertrichosis, and persistent stem cell transplantation and targeted therapy-induced alopecia. The information contained in this continuing medical education series should facilitate a better understanding on hair disorders in cancer survivors so that adequate support and therapies may be provided.",
keywords = "alopecia, cancer survivors, cancer therapy, endocrine therapy, hirsutism, hypertrichosis, persistent alopecia, persistent chemotherapy-induced alopecia, persistent radiotherapy-induced alopecia, quality of life, therapeutic transplants",
author = "Azael Freites-Martinez and Jerry Shapiro and {van den Hurk}, Corina and Shari Goldfarb and Jimenez, {Joaquin J.} and Rossi, {Anthony M.} and Ralf Paus and Lacouture, {Mario E.}",
year = "2019",
month = "5",
day = "1",
doi = "10.1016/j.jaad.2018.03.056",
language = "English (US)",
volume = "80",
pages = "1199--1213",
journal = "Journal of the American Academy of Dermatology",
issn = "0190-9622",
publisher = "Mosby Inc.",
number = "5",

}

TY - JOUR

T1 - Hair disorders in cancer survivors

AU - Freites-Martinez, Azael

AU - Shapiro, Jerry

AU - van den Hurk, Corina

AU - Goldfarb, Shari

AU - Jimenez, Joaquin J.

AU - Rossi, Anthony M.

AU - Paus, Ralf

AU - Lacouture, Mario E.

PY - 2019/5/1

Y1 - 2019/5/1

N2 - With increasing survival rates across all cancers, survivors represent a growing population that is frequently affected by persistent or permanent hair growth disorders as a result of systemic therapies, radiotherapy, surgical procedures, and therapeutic transplants. These hair disorders include persistent chemotherapy-induced alopecia, persistent radiotherapy-induced alopecia, endocrine therapy–induced alopecia and hirsutism, postsurgery alopecia and localized hypertrichosis, and persistent stem cell transplantation and targeted therapy-induced alopecia. The information contained in this continuing medical education series should facilitate a better understanding on hair disorders in cancer survivors so that adequate support and therapies may be provided.

AB - With increasing survival rates across all cancers, survivors represent a growing population that is frequently affected by persistent or permanent hair growth disorders as a result of systemic therapies, radiotherapy, surgical procedures, and therapeutic transplants. These hair disorders include persistent chemotherapy-induced alopecia, persistent radiotherapy-induced alopecia, endocrine therapy–induced alopecia and hirsutism, postsurgery alopecia and localized hypertrichosis, and persistent stem cell transplantation and targeted therapy-induced alopecia. The information contained in this continuing medical education series should facilitate a better understanding on hair disorders in cancer survivors so that adequate support and therapies may be provided.

KW - alopecia

KW - cancer survivors

KW - cancer therapy

KW - endocrine therapy

KW - hirsutism

KW - hypertrichosis

KW - persistent alopecia

KW - persistent chemotherapy-induced alopecia

KW - persistent radiotherapy-induced alopecia

KW - quality of life

KW - therapeutic transplants

UR - http://www.scopus.com/inward/record.url?scp=85064260932&partnerID=8YFLogxK

UR - http://www.scopus.com/inward/citedby.url?scp=85064260932&partnerID=8YFLogxK

U2 - 10.1016/j.jaad.2018.03.056

DO - 10.1016/j.jaad.2018.03.056

M3 - Review article

C2 - 29660423

AN - SCOPUS:85064260932

VL - 80

SP - 1199

EP - 1213

JO - Journal of the American Academy of Dermatology

JF - Journal of the American Academy of Dermatology

SN - 0190-9622

IS - 5

ER -